Sep 14 - 16, 2019
 State of the Art Echocardiography
  Meeting Type:Conference
  Description:This State-of-the-Art Echocardiography course highlights practical issues in echocardiography using a case-based format that is salient to all aspects of cardiovascular clinical practice.

The focus will be on providing guidance for optimal utilization of echocardiography in the management of valvular heart disease, heart failure and device therapies, cardiomyopathies and endocarditis. Special sessions will be dedicated to structural heart interventions, adult congenital cardiology, innovative imaging technologies and multimodality imaging.

Attendees will also learn about the most current, relevant research studies along with updates on new guidelines and hear experts’ analyses of cutting-edge technical innovations. Interact with multidisciplinary panels of experts including cardiologists with expertise in structural heart interventions, heart failure, electrophysiology and multi-modality imaging, cardiac surgeons, and cardiothoracic anesthesiologists as they debate management of challenging cases.
  Location:Hilton Cleveland Downtown      Cleveland, OH   USA
  Director(s):Richard A. Grimm, DO, FACC, FASE, Brian Griffin, MD, FACC
  Sponsor:Cleveland Clinic and the American Society of Echocardiography
  Comments:Learning Objectives:
• Describe the most appropriate methods for imaging and quantifying complex valvular heart disease using basic and advanced imaging techniques including 2D and 3D echocardiography, strain and multimodality imaging
• Discuss the role of echocardiography to diagnose and evaluate complications of endocarditis
• Describe the use of echocardiography in the diagnosis and management of special populations including those with adult congenital heart disease, cardiomyopathies, athletes and advanced heart failure
• Discuss the challenges and limitations in the assessment of diastolic function
• Describe the utility of 2D and 3D echo in guiding structural heart interventions
• Discuss specific challenges with individual structural interventions and the value of echocardiography to address these
• Review the utility of echocardiography in the management of device therapy in heart failure
• Recognize procedure specific complications of structural interventions and device therapies and how to identify these using echocardiography to improve outcomes
• Critically appraise new ACC and ASE valve guidelines and assess their impact on clinical practice

  Web Address:Visit the Website
  Brochure Link:Download The Brochure
  Get the Map:Get the Google Map
   
   
  Oct 2 - 5, 2019
 Echo in Congenital Heart Disease: Special Emphasis on Adult Congenital Heart Disease: Including Uses of Multimodality Imaging
  Meeting Type:Conference
  Description:The 35th Annual Echocardiography in Pediatric and Adult Congenital Heart Disease Symposium will highlight the use of echocardiography and other cardiac imaging techniques to recognize, understand, and manage patients with congenital heart disease using a case based format. This three-day symposium is designed to provide a comprehensive understanding of the anatomy, clinical aspects, imaging, and management of patients with congenital heart disease. The symposium will include case discussions, didactic seminars, anatomic and imaging correlations, discussion of multimodality imaging and live, hands-on scanning seminars to illustrate the impact of cardiac imaging on treatment, diagnosis, and management of patients with congenital heart disease.
  Location:Hyatt Regency Coconut Point Resort and Spa      Bonita Springs, FL   USA
  Director(s):Patrick W. O'Leary, M.D. Frank Cetta, M.D. Crystal R. Bonnichsen, M.D. M. Yasir Qureshi, MBBS
  Sponsor:Mayo Clinic Cardiovascular Medicine CME
  Comments:
COURSE LEARNING OBJECTIVES

Upon conclusion of this program, participants should be able to:
•  Describe the anatomy and physiology of common congenital cardiac conditions as well as the surgical/interventional procedures used to treat them
•  Interpret 2-D echo/Doppler hemodynamics in the setting of congenital heart disease
•  Recognize limitations of echocardiography and other imaging techniques
•  Integrate the most up-to-date echocardiographic and multimodality imaging techniques into patient management
  Phone:800.283.6296
  Email:cvcme@mayo.edu
  Web Address:Visit the Website
  Get the Map:Get the Google Map
   
   
  Oct 10 - 12, 2019
 The Genetics of Heart & Vascular Disease
  Meeting Type:Conference
  Description:During this 3 day CME course, experts in the field of cardiovascular genetics detail the important role of genetics, genomics, and pharmacogenetics in the diagnosis, risk stratification, and treatment of diseases affecting the heart and the blood vessels.

Topics covered will include, Genetics Genomics 101, pharmacogenetics, polygenic risk scores, variant interpretation, the molecular autopsy, and the diagnostic, prognostic, & therapeutic implications of genetic testing for patients with congenital heart disease, long QT syndrome, Brugada syndrome, hypertrophic/dilated/arrhythmogenic cardiomyopathy, coronary heart disease, hyperlipidemias, heart failure, pulmonary hypertension, cardiac amyloid, and the aortopathies.

Unique Features: Audience response system to enhance immediate feedback. Easy access to faculty members. One-on-one interaction. Efforts will be made to introduce the clinical applications using new technology, however, there is no hands-on experience provided. Self-assessment questions to gauge outcome. A special workshop will be conducted to analyze a genetic test report and to comment on the significance of genetic test results from your patients.
  Location:The Meritage Resort and Spa      Napa, CA   USA
  Director(s):Michael J. Ackerman, M.D., Ph.D., Naveen Pereira, M.D., Iftikhar J. Kullo, M.D.
  Sponsor:Mayo Clinic Cardiovascular Medicine CME
  Comments:Upon conclusion of this program, participants should be able to:
• Summarize the probabilistic nature of genetic testing and develop a strategy to manage the variant of uncertain significance (VUS) test result
• Identify the impact of genetic testing in the diagnosis, risk stratification, and treatment of patients with heritable cardiomyopathies, channelopathies, pulmonary hypertension, cardiac amyloidosis, and aortopathies
• Determine the role of genetic testing in children and adults with congenital heart disease
• Define genetic markers of atherosclerosis and the role of genetic risk scores (GRS) in risk stratification of coronary heart disease
• Identify the genetic basis of heritable lipid disorders and implications for prevention and familial screening
• Define the role of genetics in cardiovascular drug response and to utilize genetics to minimize adverse events and maximize drug efficacy
  Phone:800.283.6296
  Email:cvcme@mayo.edu
  Web Address:Visit the Website
  Get the Map:Get the Google Map
   
   
  Oct 17 - 18, 2019
 Fetal Echocardiography
  Meeting Type:Conference
  Description:This two-day program provides a comprehensive introduction to the science and practice of fetal echocardiography. The course will provide an understanding of the unique requirements of fetal echo in the diagnosis of structural malformations of the heart and will also include the use of pulsed, continuous wave, and color Doppler as well as M-mode in fetal cardiovascular diagnosis. Findings from the ultrasonographic/Doppler assessment of fetal cardiovascular physiology will be related to the pre- and postnatal management of congenital heart disease. Throughout the program the clinical importance of observations made during the fetal echo exam will be detailed.
  Location:Thomas Jefferson University Hospital      Philadelphia, PA   USA
  Email:jurei@jefferson.edu
  Web Address:Visit the Website
   
   
 
 
   
© 1999- 2019 Echo-Web, LLC . All Rights Reserved
terms under which this service is provided to you. Read our privacy guidelines.
962  
     

Recommended For You

Order Now

 

 

 



a global resource in cardiovascular education